Diabetologia

Journal

Publication Venue For

  • Diabetes, GDF-15 and incident heart failure: the atherosclerosis risk in communities study.  65:955-963. 2022
  • Multi-ethnic GWAS and fine-mapping of glycaemic traits identify novel loci in the PAGE Study.  65:477-489. 2022
  • The CREBRF diabetes-protective rs373863828-A allele is associated with enhanced early insulin release in men of Māori and Pacific ancestry.  64:2779-2789. 2021
  • Depleting hypothalamic somatostatinergic neurons recapitulates diabetic phenotypes in mouse brain, bone marrow, adipose and retina.  64:2575-2588. 2021
  • The Pacific-specific CREBRF rs373863828 allele protects against gestational diabetes mellitus in Māori and Pacific women with obesity.  63:2169-2176. 2020
  • Cumulative average dietary pattern scores in young adulthood and risk of incident type 2 diabetes: the CARDIA study.  62:2233-2244. 2019
  • Fasting glucose variability in young adulthood and incident diabetes, cardiovascular disease and all-cause mortality.  62:1366-1374. 2019
  • Ideal cardiovascular health, glycaemic status and incident type 2 diabetes mellitus: the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.  62:426-437. 2019
  • Skin autofluorescence predicts incident type 2 diabetes, cardiovascular disease and mortality in the general population.  62:269-280. 2019
  • Identification of novel high-impact recessively inherited type 2 diabetes risk variants in the Greenlandic population.  61:2005-2015. 2018
  • Discordant association of the CREBRF rs373863828 A allele with increased BMI and protection from type 2 diabetes in Māori and Pacific (Polynesian) people living in Aotearoa/New Zealand.  61:1603-1613. 2018
  • Associations between SLC16A11 Variants and Type 2 Diabetes in the Hispanic Community Health Study/Study of Latinos 2017
  • Effects of a long-term lifestyle modification programme on peripheral neuropathy in overweight or obese adults with type 2 diabetes: the Look AHEAD study.  60:980-988. 2017
  • Twenty year fitness trends in young adults and incidence of prediabetes and diabetes: the CARDIA study.  59:1659-1665. 2016
  • Marijuana use and risk of prediabetes and diabetes by middle adulthood: the Coronary Artery Risk Development in Young Adults (CARDIA) study.  58:2736-2744. 2015
  • FGF21 is not required for glucose homeostasis, ketosis or tumour suppression associated with ketogenic diets in mice.  58:2414-2423. 2015
  • Prospective association of a genetic risk score and lifestyle intervention with cardiovascular morbidity and mortality among individuals with type 2 diabetes: the Look AHEAD randomised controlled trial.  58:1803-1813. 2015
  • The FOXP1, FOXP2 and FOXP4 transcription factors are required for islet alpha cell proliferation and function in mice.  58:1836-1844. 2015
  • A genotype risk score predicts type 2 diabetes from young adulthood: The CARDIA study.  55:2604-2612. 2012
  • Erratum: Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: A systematic review and meta-analysis (Diabetologia DOI 10.1007/s00125-012-2638-6).  55:2858-2859. 2012
  • Activating transcription factor 4 mediates hyperglycaemia-induced endothelial inflammation and retinal vascular leakage through activation of STAT3 in a mouse model of type 1 diabetes.  55:2533-2545. 2012
  • Fat-induced membrane cholesterol accrual provokes cortical filamentous actin destabilisation and glucose transport dysfunction in skeletal muscle.  55:457-467. 2012
  • Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: A systematic review and meta-analysis.  55:2636-2645. 2012
  • Association of the SLC30A8 missense polymorphism R325W with proinsulin levels at baseline and after lifestyle, metformin or troglitazone intervention in the Diabetes Prevention Program..  54:2570-2574. 2011
  • C-reactive protein promotes diabetic kidney disease in a mouse model of type 1 diabetes.  54:2713-2723. 2011
  • Decreased progression to diabetes in subjects with prediabetes after 2 years of treatment with controlled-release phentermine/topiramate.  54:S371-S371. 2011
  • Long-term weight loss with controlled-release phentermine/topiramate reverses metabolic syndrome and improves associated traits.  54:S370-S370. 2011
  • Endothelin receptor A-specific stimulation of glomerular inflammation and injury in a streptozotocin-induced rat model of diabetes.  54:979-988. 2011
  • Colesevelam for Hispanic patients with hypercholesterolaemia and prediabetes.  53. 2010
  • Initial treatment with metformin plus colesevelam provides greater glycaemic control than metformin alone in Hispanic patients with type 2 diabetes mellitus.  53. 2010
  • Once-daily, low-dose, controlled-release phentermine/topiramate results in significant clinical improvements in overweight/obese patients with type 2 diabetes.  53. 2010
  • Phentermine/topiramate combination therapy significantly improves glucose impairment in overweight/obese patients.  53. 2010
  • Cardiovascular disease risk factors, depression symptoms and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes..  53:1581-1589. 2010
  • Glucosamine increases hexosamine biosynthesis and O-linked N-acetylglucosamine in the heart, and leads to metabolic alterations similar to those seen in diabetic cardiomyopathy.  52:S15-S15. 2009
  • Treatment with VI-0521 (phentermine and topiramate) leads to one year durable glycaemic benefit and weight loss in subjects with type 2 diabetes.  52:S77-S77. 2009
  • Association of fetuin-A with decreased serum triglyceride after six weeks of extended-release niacin intervention in individuals with metabolic syndrome.  51:S374-S374. 2008
  • Changes in O-linked N-acetylglucosamine is associated with diabetic nephropathy in the human kidney.  51:S488-S488. 2008
  • HbA1c measured in stored erythrocytes and mortality rate among middle-aged and older women.  51:267-275. 2008
  • Genotype-by-sex interaction in the aetiology of type 2 diabetes mellitus: Support for sex-specific quantitative trait loci in Hypertension Genetic Epidemiology Network participants.  49:2329-2336. 2006
  • Erratum: Genome-wide scans for heritability of fasting serum insulin and glucose concentrations in hypertensive families (Diabetologia (2005) 48 (661-668) DOI: http://dx.doi.org/10.1007/s00125-005-1679-5).  48:1678. 2005
  • Genome-wide scans for heritability of fasting serum insulin and glucose concentrations in hypertensive families.  48:661-668. 2005
  • Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention: The DREAM trial.  47:1519-1527. 2004
  • A genome scan for loci linked to quantitative insulin traits in persons without diabetes: The Framingham Offspring Study.  46:579-587. 2003
  • Oxidant regulation of gene expression and neural tube development: Insights gained from diabetic pregnancy on molecular causes of neural tube defects.  46:538-545. 2003
  • Inflammation and the insulin healthy subjects. The atherosclerosis study (IRAS)..  42:A60-A60. 1999
  • Genome scan for linkage to pre-diabetic traits in Pima Indians.  40:615-615. 1997
  • Variability of the pancreatic islet beta cell/liver (GLUT 2) glucose transporter gene in NIDDM patients.  37:420-427. 1994
  • Glucokinase gene in gestational diabetes mellitus: population association study and molecular scanning.  37:104-110. 1994
  • Short-term regulation of insulin-mediated glucose utilization in four-day fasted human volunteers: role of amino acid availability.  35:357-366. 1992
  • Effect of haemolysis on radioimmunoassay for insulin.  31:403-404. 1988
  • Induction of class II MHC antigens on human and rodent islet parenchymal cells in vitro..  30:441. 1987
  • Physical activity and prevalence of diabetes in Melanesian and Indian men in Fiji.  27:578-582. 1984
  • Class I, II and III major histocompatibility complex gene polymorphisms in BB rats.  27:77-79. 1984
  • The complement component C4 in black Americans with Type 1 (insulin-dependent) diabetes mellitus.  26:166-168. 1984
  • The prevalence of diabetes mellitus and impaired glucose tolerance in melanesians and part-polynesians in Rural New Caledonia and ouvea (Loyalty Islands).  23:393-398. 1982
  • Properdin factor B in black Type 1 (insulin-dependent) diabetic patients.  22:483-485. 1982
  • Binding and degradation of 125I-insulin by renal glomeruli and tubules isolated from rats.  22:276-284. 1982
  • International Standard Serial Number (issn)

  • 0012-186X
  • Electronic International Standard Serial Number (eissn)

  • 1432-0428